Study of DS-8201a, an Antibody Drug Conjugate for Advanced Breast Cancer Patients, With Biomarkers Analysis
Condition: Breast Tumors Intervention: Drug: DS-8201a Sponsors: UNICANCER; Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials